NL-OMON29290已完成不适用
Second Dutch Lupus Nephritis trial.
未提供0 个研究点目标入组 124 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 124
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age 18 - 70 yrs;
- •2. SLE (presence of at least 4 ACR-criteria for SLE;
- •3. Proliferative lupus nephritis:
- •a. Biopsy proven lupus nephritis WHO class III or IV (according to Churg 1995).
- •b. Active sediment”. > 5 ery’s per HPF and/or celcylinders
- •c. Proteïnuria > 0.5 g/day;
- •4. Adequate anticonception;
- •5. Informed consent.
排除标准
- •1. Active infection;
- •2. Pregnancy;
- •3. Known allergy for one of the study drugs;
- •4. Malignancy < 5 years prior to inclusion.
研究者
相似试验
已完成
2 期
Abatacept and Cyclophosphamide Combination Therapy for Lupus NephritisLupus Erythematosus, SystemicLupus NephritisNCT00774852National Institute of Allergy and Infectious Diseases (NIAID)137
撤回
4 期
Pentoxifylline in Lupus NephritisLupus NephritisNCT03859570MetroHealth Medical Center
尚未招募
不适用
Metabolomics study of biopsy-proven lupus nephritisupus nephritisLupus nephritisTCTR20230321004Faculty of medicine Siriraj hospital191
终止
3 期
Efficacy and Safety Study of Abatacept to Treat Lupus NephritisLupus NephritisNCT01714817Bristol-Myers Squibb695
Unknown
2 期
Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)Lupus NephritisNCT03580291Lingyun Sun230